Inhibition of HSP90 with NVP-AUY922 induces a synergistic effect in HER2-amplified, trastuzumab-resistant breast and gastric cancer

被引：0
|
作者：
Wainberg, Zev A. [1 ]
Rogers, Amy [1 ]
O'Brien, Neil [1 ]
Anghel, Adrian [1 ]
Desai, Amrita [1 ]
Kalous, Ondrej [1 ]
Conklin, Dylan [1 ]
Akimov, Mikhail [2 ]
Finn, Richard S. [1 ]
Slamon, Dennis J. [1 ]
机构：
[1] Univ Calif Los Angeles, Med Ctr Santa Monica, Santa Monica, CA USA
[2] Novartis, Basel, Switzerland
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-3668
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3668
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The Hsp90 inhibitor, NVP-AUY922, produces anti-tumour activity through inhibition of fibronectin polymerization resulting in cytoskeletal reorganization
    Armstrong, Heather
    Butler, Lisa
    Selth, Luke
    Tarulli, Gerard
    Centenera, Margaret
    BJU INTERNATIONAL, 2015, 116 : 39 - 39
  • [32] 2-phenylethynesulphonamide (PFT-) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels
    Yeramian, Andree
    Vea, Alvar
    Benitez, Sandra
    Ribera, Joan
    Domingo, Monica
    Santacana, Maria
    Martinez, Montserrat
    Maiques, Oscar
    Valls, Joan
    Dolcet, Xavier
    Vilella, Ramon
    Cabiscol, Elisa
    Matias-Guiu, Xavier
    Marti, Rosa M.
    PIGMENT CELL & MELANOMA RESEARCH, 2016, 29 (03) : 352 - 371
  • [33] Phase IB/II study of the HSP90 inhibitor AUY922, in combination with trastuzumab, in patients with HER2+advanced breast cancer
    Kong, Anthony
    Rea, Daniel
    Ahmed, Samreen
    Beck, J. Thaddeus
    Lopez, Rafael Lopez
    Biganzoli, Laura
    Armstrong, Anne
    Aglietta, Massimo
    Alba, Emilio
    Campone, Mario
    Akimov, Mikhail
    Matano, Alessandro
    Lefebvre, Caroline
    Lee, Soo-Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Hsp90 inhibitor (NVP-AUY922) enhances anti-cancer effect of Bcl-2 inhibitor (ABT-737) in small cell lung cancer
    Yang, Hannah
    Park, Kang-Seo
    Choi, Junyoung
    Kim, Sang-We Kim
    Lee, Dae Ho
    CANCER RESEARCH, 2017, 77
  • [35] Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer
    Scaltriti, Maurizio
    Serra, Violeta
    Normant, Emmanuel
    Guzman, Marta
    Rodriguez, Olga
    Lim, Alice R.
    Slocum, Kelly L.
    West, Kip A.
    Rodriguez, Varenka
    Prudkin, Ludmila
    Jimenez, Jose
    Aura, Claudia
    Baselga, Jose
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (05) : 817 - 824
  • [36] Novel HSP90 Inhibitor NVP-AUY922 Enhances the Anti-tumor Effect of Temsirolimus Against Oral Squamous Cell Carcinoma
    Okui, Tatsuo
    Shimo, Tsuyoshi
    Fukazawa, Takuya
    Hassan, Nur Mohammad Monsur
    Honami, Tatsuki
    Ibaragi, Soichiro
    Takaoka, Munenori
    Naomoto, Yoshio
    Sasaki, Akira
    CURRENT CANCER DRUG TARGETS, 2013, 13 (03) : 289 - 299
  • [37] HSP90 inhibitor, AUY922, debilitates intrinsic and acquired lapatinib-resistant HER2-positive gastric cancer cells
    Park, Kang-Seo
    Hong, Yong Sang
    Choi, Junyoung
    Yoon, Shinkyo
    Kang, Jihoon
    Kim, Deokhoon
    Lee, Kang-Pa
    Im, Hyeon-Su
    Lee, Chang Hoon
    Seo, Seyoung
    Kim, Sang-We
    Lee, Dae Ho
    Park, Sook Ryun
    BMB REPORTS, 2018, 51 (12) : 660 - 665
  • [38] Effect of Hsp90 inhibitor NVP-AUY922 with radiation on lung adenocarcinoma cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors
    Maki, Yuho
    Hashida, Shinsuke
    Yamamoto, Hiromasa
    Shien, Kazuhiko
    Ohtsuka, Tomoaki
    Suzawa, Ken
    Furukawa, Masashi
    Soh, Junichi
    Asano, Hiroaki
    Tsukuda, Kazunori
    Miyoshi, Shinichiro
    Kanazawa, Susumu
    Toyooka, Shinichi
    CANCER RESEARCH, 2015, 75
  • [39] Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors
    Hashida, Shinsuke
    Yamamoto, Hiromasa
    Shien, Kazuhiko
    Ohtsuka, Tomoaki
    Suzawa, Ken
    Maki, Yuho
    Furukawa, Masashi
    Soh, Junichi
    Asano, Hiroaki
    Tsukuda, Kazunori
    Miyoshi, Shinichiro
    Kanazawa, Susumu
    Toyooka, Shinichi
    ONCOLOGY REPORTS, 2015, 33 (03) : 1499 - 1504
  • [40] Radiation response of tumor cell lines after combined PI3K/mTOR and Hsp90 inhibition by PI-103 and NVP-AUY922
    Roloff, K.
    Katzer, A.
    Polat, B.
    Flentje, M.
    Djuzenova, C. S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 127 - 127
12345